SEC Comment Letter 0000000000-23-007747 to Alvotech (ALVO)
Alvotech
Date: July 20, 2023 · CIK: 0001898416 · Accession: 0000000000-23-007747
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-273262
Letter
United States securities and exchange commission logo July 20, 2023 Joel Morales Chief Executive Officer Alvotech 9, Rue de Bitbourg L-1273 Luxembourg Grand Duchy of Luxembourg Re:Alvotech Registration Statement on Form F-3 Filed July 14, 2023 File No. 333-273262 Dear Joel Morales: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Dillon Hagius at 202-551-7967 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Nicolas H.R. Dumont
Show Raw Text
United States securities and exchange commission logo
July 20, 2023
Joel Morales
Chief Executive Officer
Alvotech
9, Rue de Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg
Re:Alvotech
Registration Statement on Form F-3
Filed July 14, 2023
File No. 333-273262
Dear Joel Morales:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Dillon Hagius at 202-551-7967 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Nicolas H.R. Dumont